Overview

Efficacy and Safety of Desmopressin Melt for the Treatment of Nocturia

Status:
Completed
Trial end date:
2008-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the efficacy and safety of several doses of the melt formulation of desmopressin in a broad population of adult patients with nocturia.
Phase:
Phase 3
Details
Lead Sponsor:
Ferring Pharmaceuticals
Treatments:
Deamino Arginine Vasopressin